- Home
- CIM vs LENZ Comparison
CIM vs LENZ Comparison
Compare CIM & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIM
- LENZ
- Stock Information
- Founded
- CIM 2007
- LENZ 2019
- Country
- CIM United States
- LENZ United States
- Employees
- CIM N/A
- LENZ N/A
- Industry
- CIM Real Estate Investment Trusts
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- CIM Real Estate
- LENZ Health Care
- Exchange
- CIM Nasdaq
- LENZ Nasdaq
- Market Cap
- CIM 865.9M
- LENZ 729.6M
- IPO Year
- CIM 2007
- LENZ 2021
- Fundamental
- Price
- CIM $11.39
- LENZ $23.82
- Analyst Decision
- CIM Hold
- LENZ Strong Buy
- Analyst Count
- CIM 2
- LENZ 5
- Target Price
- CIM $16.00
- LENZ $40.20
- AVG Volume (30 Days)
- CIM 867.7K
- LENZ 297.4K
- Earning Date
- CIM 05-08-2025
- LENZ 03-19-2025
- Dividend Yield
- CIM 13.01%
- LENZ N/A
- EPS Growth
- CIM 61.77
- LENZ N/A
- EPS
- CIM 1.10
- LENZ N/A
- Revenue
- CIM $277,886,000.00
- LENZ N/A
- Revenue This Year
- CIM $9.17
- LENZ N/A
- Revenue Next Year
- CIM $1.73
- LENZ $539.55
- P/E Ratio
- CIM $10.35
- LENZ N/A
- Revenue Growth
- CIM 22.95
- LENZ N/A
- 52 Week Low
- CIM $9.85
- LENZ $14.42
- 52 Week High
- CIM $16.89
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- CIM 39.57
- LENZ 52.20
- Support Level
- CIM $10.94
- LENZ $21.91
- Resistance Level
- CIM $11.30
- LENZ $24.39
- Average True Range (ATR)
- CIM 0.62
- LENZ 2.26
- MACD
- CIM -0.03
- LENZ 0.15
- Stochastic Oscillator
- CIM 49.68
- LENZ 67.67
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.